Is the biotech industry truly out of its slump? Why are employers dropping coverage of weight loss drugs? And what will the hosts bake for the holidays?
We discuss all that and more on this week’s episode of “The Readout LOUD,” the last episode of the year. We bring on Bruce Booth, partner at venture capital firm Atlas Venture, to reflect on everything that’s happened in the biotech industry this year and to look ahead at the trends next year.
We also chat about Adam’s picks for best and worst biopharma CEOs in 2025, and why Eli Lilly and Novo Nordisk’s direct-to-consumer offerings may be contributing to employers’ decisions to drop coverage of weight loss drugs.
To read more on Adam’s picks for best CEOs, go here; for more on his pick for worst CEO, go here; and for more on employers dropping coverage of weight loss drugs, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
